NKT THERAPEUTICS INC has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are LABRYS BIOLOG INC, VELVET ANTLER RES NEW ZEALAND and MEDEXGEN CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Hong Kong | 2 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Israel | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Medical purpose containers |
# | Name | Total Patents |
---|---|---|
#1 | Carr Francis Joseph | 12 |
#2 | Truneh Alemseged | 12 |
#3 | Jones Timothy David | 12 |
#4 | Gregson James P | 11 |
#5 | Schaub Robert | 4 |
#6 | Scheuplein Hans Albert Felix | 4 |
#7 | Mashal Robert | 2 |
#8 | Alemseged Trune | 1 |
#9 | Gregson James P P | 1 |
#10 | Timothy David Jones | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016018850A1 | Combination therapy with il-12 | |
AU2015202812A1 | Humanized antibodies to iNKT | |
WO2015069697A2 | Combination therapy | |
SG11201401319XA | Humanized antibodies to inkt |